Zobrazeno 1 - 3
of 3
pro vyhledávání: '"E. A. J. Willemse"'
Publikováno v:
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-11 (2021)
Abstract Background Neurofilament light in serum (sNfL) is a biomarker for axonal damage with elevated levels in many neurological disorders, including neurodegenerative dementias. Since within-group variation of sNfL is large and concentrations incr
Externí odkaz:
https://doaj.org/article/23f8098e8f1d46f8907f5296920daf87
Publikováno v:
Alzheimer's Research and Therapy, 13(1):101. BioMed Central
Alzheimer's Research & Therapy
Willemse, E A J, Scheltens, P, Teunissen, C E & Vijverberg, E G B 2021, ' A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study ', Alzheimer's Research and Therapy, vol. 13, no. 1, 101 . https://doi.org/10.1186/s13195-021-00841-4
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-11 (2021)
Alzheimer's Research & Therapy
Willemse, E A J, Scheltens, P, Teunissen, C E & Vijverberg, E G B 2021, ' A neurologist’s perspective on serum neurofilament light in the memory clinic: a prospective implementation study ', Alzheimer's Research and Therapy, vol. 13, no. 1, 101 . https://doi.org/10.1186/s13195-021-00841-4
Alzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-11 (2021)
Background Neurofilament light in serum (sNfL) is a biomarker for axonal damage with elevated levels in many neurological disorders, including neurodegenerative dementias. Since within-group variation of sNfL is large and concentrations increase with
Publikováno v:
Handbook of clinical neurology. 146
Cerebrospinal fluid (CSF) is an extremely useful matrix for biomarker research for several purposes, such as diagnosis, prognosis, monitoring, and identification of prominent leads in pathways of neurologic diseases. Such biomarkers can be identified